PharVision Advisers’s Amer Sports AS Stock Holding History

PharVision Advisers’s Portfolio AS Stock Details AS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,443	Closed	-$250K	–	822
2025 Q2	$250K	Buy	+6,443	New	+$198K	0.36%	138

Other funds holding AS

FCCPG

FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Candlestick Capital Management Greenwich, Connecticut $4.12B AUM 50.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

WT Asset Management Hong Kong $4.77B AUM 334.05% 1-Year Est. Return

PharVision Advisers's AS Position: Q3 2025 in Review

PharVision Advisers sold out of Amer Sports (AS) in Q3 2025, closing a stake of 6,443 shares — an estimated $250K sold.

PharVision Advisers first reported a position in AS in Q2 2025 and held it in 1 quarter. The position peaked at $250K in Q2 2025. 326 funds tracked by Wall St. Rank hold AS as of Q3 2025.

PharVision Advisers reported no remaining Amer Sports position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 6,443 Amer Sports shares in Q3 2025, an estimated $250K.
PharVision Advisers first reported a position in Amer Sports in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Amer Sports position peaked at $250K in Q2 2025.
326 funds tracked by Wall St. Rank held Amer Sports as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.